Nuzenio

Galectin Therapeutics

Galectin Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 7 publisher sources 100/100 entity strength

Latest news

Galectin Therapeutics (GALT) Projected to Announce Quarterly Earnings on Thursday - MarketBeatMarketBeat · Thu, 06 Aug 2026 06:26:53 GMT Galectin Therapeutics strengthens balance sheet via debt-to-equity conversion - The Globe and MailThe Globe and Mail · Wed, 05 Aug 2026 12:34:00 GMT Galectin Therapeutics Eliminates $105.8 Million in Debt Through Equity Conversion - citybizcitybiz · Tue, 04 Aug 2026 13:37:08 GMT Richard Uihlein converts GALT debt into 34,376,167 new shares - Stock TitanStock Titan · Tue, 04 Aug 2026 12:30:40 GMT Galectin Therapeutics Announces Conversion of $105.8 Million in Debt to Equity, Significantly Strengthening Balance Sheet - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 12:00:00 GMT Galectin Therapeutics (GALT) director converts credit notes into stock - Stock TitanStock Titan · Tue, 04 Aug 2026 11:52:56 GMT Galectin chair Uihlein receives 34,376,167 shares in debt-to-equity conversion - BitgetBitget · Tue, 04 Aug 2026 07:00:00 GMT Bronstein, Gewirtz & Grossman, LLC Is Investigating Galectin Ther - The National Law ReviewThe National Law Review · Tue, 04 Aug 2026 02:09:56 GMT

Timeline

Thu, 06 Aug 2026 06:26:53 GMTGalectin Therapeutics (GALT) Projected to Announce Quarterly Earnings on Thursday - MarketBeat

Wed, 05 Aug 2026 12:34:00 GMTGalectin Therapeutics strengthens balance sheet via debt-to-equity conversion - The Globe and Mail

Tue, 04 Aug 2026 13:37:08 GMTGalectin Therapeutics Eliminates $105.8 Million in Debt Through Equity Conversion - citybiz

Tue, 04 Aug 2026 12:30:40 GMTRichard Uihlein converts GALT debt into 34,376,167 new shares - Stock Titan

Tue, 04 Aug 2026 12:00:00 GMTGalectin Therapeutics Announces Conversion of $105.8 Million in Debt to Equity, Significantly Strengthening Balance Sheet - Yahoo Finance

Tue, 04 Aug 2026 11:52:56 GMTGalectin Therapeutics (GALT) director converts credit notes into stock - Stock Titan

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.

Connected entities

GALT8 live mentions Million4 live mentions Conversion3 live mentions Uihlein3 live mentions Projected2 live mentions Announce Quarterly Earnings2 live mentions MarketBeat Galectin Therapeutics2 live mentions The Globe2 live mentions Galectin Therapeutics Eliminates2 live mentions Debt Through Equity2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Galectin Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.